Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1995 2
1997 5
1998 2
1999 5
2000 3
2001 5
2002 2
2003 5
2004 7
2005 11
2006 10
2007 20
2008 25
2009 45
2010 4
2011 2
2012 4
2013 1
2014 2
2015 2
2016 2
2017 1
2018 1
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 19528476

158 results
Results by year
Filters applied: . Clear all
Page 1
Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F. Ishida D, et al. Cancer Lett. 2010 Feb 1;288(1):17-27. doi: 10.1016/j.canlet.2009.06.014. Epub 2009 Jul 14. Cancer Lett. 2010. PMID: 19604626
Virus-directed enzyme prodrug therapy using CB1954.
Grove JI, Searle PF, Weedon SJ, Green NK, McNeish IA, Kerr DJ. Grove JI, et al. Anticancer Drug Des. 1999 Dec;14(6):461-72. Anticancer Drug Des. 1999. PMID: 10834268 Review.
Nitroreductase: a prodrug-activating enzyme for cancer gene therapy.
Searle PF, Chen MJ, Hu L, Race PR, Lovering AL, Grove JI, Guise C, Jaberipour M, James ND, Mautner V, Young LS, Kerr DJ, Mountain A, White SA, Hyde EI. Searle PF, et al. Clin Exp Pharmacol Physiol. 2004 Nov;31(11):811-6. doi: 10.1111/j.1440-1681.2004.04085.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15566399 Review.
158 results